Plain-English translation of NCT07440511 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a newer ultrasound technique called spleen stiffness measurement to better detect advanced liver scarring (fibrosis) in people with metabolic-dysfunction associated fatty liver disease. The technique measures how stiff your spleen has become, which can indicate how advanced your liver disease is. Researchers believe this non-invasive scan could help doctors catch serious liver disease earlier and avoid the need for more invasive procedures like liver biopsies.
Currently, doctors use invasive procedures like liver biopsies to confirm advanced liver disease. This trial exists because researchers have found that the new ultrasound technique may work just as well—or better—at detecting dangerous liver scarring without the risks and discomfort of a biopsy. Early and accurate detection could help prevent progression to cirrhosis or liver cancer.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will undergo ultrasound scans to measure your spleen stiffness and liver stiffness. The researchers will also review your medical records and may compare your ultrasound results with blood tests and other clinical information. This is an observational study, meaning you won't be taking new medications or making major lifestyle changes—you'll simply be completing scans and sharing your health data to help the research team develop better ways to detect advanced liver disease.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Italy